AMERIPRISE FINANCIAL INC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,113,000
+59.9%
372,502
+41.7%
0.00%
Q4 2021$696,000
+340.5%
262,802
+256.0%
0.00%
Q4 2019$158,00073,830
+67018.2%
0.00%
Q3 2014$0
-100.0%
110
-21.4%
0.00%
Q2 2014$1,000
-94.7%
140
-97.4%
0.00%
Q3 2013$19,000
+5.6%
5,4320.0%0.00%
Q2 2013$18,0005,4320.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders